Evidence map›Paper›PMID 25378165›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/Akt signaling with NMDA receptor.

Tsuyoshi Nakai, Taku Nagai, Motoki Tanaka, Norimichi Itoh, Naoya Asai, Atsushi Enomoto, Masato Asai, Shinnosuke Yamada, Ali Bin Saifullah, Masahiro Sokabe and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. BDNF provides many routes toward STN DBS-mediated disease modification.Movement disorders : official journal of the Movement Disorder Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Tsuyoshi NakaiDepartments of Neuropsychopharmacology and Hospital Pharmacy.
Taku NagaiDepartments of Neuropsychopharmacology and Hospital Pharmacy.
Motoki TanakaDepartment of Mechanobiology Laboratory, and.
Norimichi ItohDepartments of Neuropsychopharmacology and Hospital Pharmacy.
Naoya AsaiDepartment of Pathology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8560, Japan.
Atsushi EnomotoDepartment of Pathology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8560, Japan.
Masato AsaiDepartment of Pathology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8560, Japan.
Shinnosuke YamadaDepartments of Neuropsychopharmacology and Hospital Pharmacy.
Ali Bin SaifullahDepartments of Neuropsychopharmacology and Hospital Pharmacy.
Masahiro SokabeDepartment of Mechanobiology Laboratory, and.
Masahide TakahashiDepartment of Pathology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8560, Japan kyamada@med.nagoya-u.ac.jp mtakaha@med.nagoya-u.ac.jp.
Kiyofumi YamadaDepartments of Neuropsychopharmacology and Hospital Pharmacy, kyamada@med.nagoya-u.ac.jp mtakaha@med.nagoya-u.ac.jp.
Nagoya University · JPChinese Academy of Agricultural Mechanization Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synaptic plasticity in hippocampal neurons has been thought to represent a variety of memories. Although accumulating evidence indicates a crucial role of BDNF/TrkB/Akt signaling in the synaptic plasticity of the hippocampus, the mechanism by which Akt, a serine/threonine kinase, controls activity-dependent neuronal plasticity remains unclear. Girdin (also known as APE, GIV, and HkRP1), an actin-binding protein involved both in the remodeling of the actin cytoskeleton and in cell migration, has been identified as a substrate of Akt. Previous studies have demonstrated that deficit of neuronal migration in the hippocampus of Girdin-deficient (Girdin(-/-)) mice is independent on serine phosphorylation of Girdin at S1416 (Girdin S1416) by Akt. In the present study, we focused on the role of Girdin S1416 phosphorylation in BDNF/TrkB/Akt signaling associated with synaptic plasticity. We found that Girdin in the hippocampus was phosphorylated at S1416 in an activity-dependent manner. Phosphorylation-deficient knock-in mice (Girdin(SA/SA) mice), in which S1416 is replaced with alanine, exhibited shrinkage of spines, deficit of hippocampal long-term potentiation, and memory impairment. These phenotypes of Girdin(SA/SA) mice resembled those of Girdin(+/-) mice, which have 50% loss of Girdin expression. Furthermore, Girdin interacted with Src kinase and NR2B subunit of NMDA receptor, leading to phosphorylation of the NR2B subunit and NMDA receptor activation. Our findings suggest that Girdin has two different functions in the hippocampus: Akt-independent neuronal migration and Akt-dependent NR2B phosphorylation through the interaction with Src, which is associated with synaptic plasticity in the hippocampus underlying memory formation.

Indexed as

Long-Term PotentiationMemoryProtein Processing, Post-TranslationalSignal TransductionAnimalsBrain-Derived Neurotrophic FactorCells, CulturedDendritic SpinesHippocampusMiceMicrofilament ProteinsNeuronsPhosphorylationProtein BindingProto-Oncogene Proteins c-aktReceptors, N-Methyl-D-AspartateBrain-Derived Neurotrophic FactorCcdc88a protein, mouseMicrofilament ProteinsNR2B NMDA receptorProto-Oncogene Proteins c-aktReceptors, N-Methyl-D-AspartateReceptor, trkBsrc-Family KinasesVesicular Transport ProteinsGirdinlong-term potentiationmemory formationmutant miceNMDA receptorphosphorylation

Identifiers

PMID25378165
PMCPMC6608366
OpenAlexW1970044109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.